A nonprofit biotechnology company based in Philadelphia has received $60 million from a TED initiative that funds "big ideas." The company, Every Cure, is using the money to further its mission of employing AI to help match existing treatments to new diseases. The company's focus stems from the personal experience of one of its founders, David Fajgenbaum, an immunologist and associate professor at University of Pennsylvania, who credits a repurposed drug with saving his life.
In a social media landscape shaped by hashtags, algorithms, and viral posts, nurse leaders must decide: Will they let the narrative spiral, or can they adapt and join the conversation?
...
